Search
XNAS • Healthcare

Aktis Oncology, Inc. (AKTS)

Pharmaceutical Preparations · 17 DRYDOCK AVENUE, SUITE #17-401, BOSTON, MA, 02210

XNASstockActive listing
15.11
+0.05 (+0.33%)
Quote updated 10/19/2026, 4:00:00 AM
Previous close15.06
Open15.19
Day range14.84 – 15.32
52-week range14.72 – 34.19
Volume353,400
Market cap862.7M
PRICE HISTORY

Stock price history and performance

Daily closing prices from the stored market history.

195 sessions
$34$29$24$19$14Jan 9Jun 1Oct 19
STOCK RESEARCH · EDITORIAL ANALYSIS

Aktis Oncology, Inc. (AKTS): Investment Research & Business Outlook

A research-led explanation of the company, its financial evidence, valuation context and risks—not just a list of market numbers.

Research note

What the available evidence tells us

The latest stored quote for Aktis Oncology, Inc. (AKTS) is 15.11, timestamped 10/19/2026, 4:00:00 AM. A quote is a point-in-time observation; it does not, by itself, explain why the price moved or establish whether the shares are attractive.

Business and financial quality

The company is classified in Pharmaceutical Preparations in the current stock database. Stored fundamentals include 33 usable headline metrics. These should be read across several reporting periods and compared with peers before drawing a conclusion about business quality.

Valuation: context matters

A usable trailing P/E value is not currently stored. Without a verified valuation metric and a relevant comparison set, this page does not label the shares cheap or expensive.

Price trend and quantitative outlook

The chart is based on 195 stored daily price observations. Historical performance describes what happened over that period; it is not a guarantee of future returns. The current stored quantitative model signal is “neutral”. Treat model outputs as scenarios with uncertainty, not as certain targets or personalized advice.

Key risks and what to watch next

Risk records exist for this company; review the risk and performance section below for the available volatility, drawdown and risk-adjusted measures. The next useful evidence to review is the company’s next reported financial results, changes in forward estimates, and primary-source disclosures.

Editorial integrity: this summary uses fields available in the current database. Missing evidence is called out rather than filled with invented facts.

What the numbers mean for investors

Business quality

Reported revenue growth is +123.01%. Growth is encouraging, but investors should confirm it is recurring and understand what product, geography or customer group is driving it.

Profitability

Gross margin is +0.00% and operating margin is -703.63%. The gap helps show how much operating costs absorb after direct costs; compare the trend with prior periods and sector peers.

Valuation

A usable P/E value is not stored. Avoid calling the shares cheap or expensive until earnings and valuation data can be verified.

Price trend

Moving-average context is incomplete, so this page avoids asserting a confirmed trend from missing indicators.

Bull case, bear case and evidence to watch

Bull case

The bullish case needs confirmation from reported revenue growth, cash generation, and future company disclosures; the current snapshot does not establish those conditions together.

Bear case

Potential downside still includes weaker demand, margin compression, competition, execution issues, or a broad market sell-off. Company-specific evidence is needed to quantify these risks.

What to watch next

Track the next earnings release, changes in revenue and margin trends, cash flow, management guidance, analyst estimate revisions, and primary-source filings. Update the thesis when new evidence arrives rather than relying on one ratio or forecast.

These interpretations are rule-based explanations of the stored fields, not independently verified company-specific forecasts. Missing data is not treated as zero; all investment cases remain conditional on new evidence.

US Market AI Research Desk · Data/research timestamp: Oct 19, 2026 · Methodology & disclaimer
QUANTITATIVE RESEARCH

Stock forecast and analysis: price outlook

Forecasts are model outputs, not promises or personalized investment advice.

neutral
HorizonModel targetExpected changeSignalConfidence score
24H14.98-0.87%neutral75
7D14.62-3.27%bearish75
30D13.79-8.75%bearish75
90D12.51-17.22%bearish75

Long-term model scenarios

Latest stored scenario per future target year. Bear, base and bull prices are model scenarios, not guaranteed targets. The relative model score is not a calibrated probability; uncertainty rises materially for distant years.

Target yearBase caseBear caseBull caseExpected CAGRRelative model scoreSignal
202718.1018.0718.131.35%67long-term-neutral
203019.4719.0219.922.18%66long-term-positive
203523.3621.3725.513.03%65long-term-positive
204028.8324.3534.063.48%62long-term-positive
205044.2331.7461.353.85%58long-term-positive
COMPANY FUNDAMENTALS

Financial performance and company fundamentals

Reported fields from the current fundamentals snapshot.

Revenue3.23MTotal sales reported for the period; compare growth across several periods.
Revenue growth+123.01%How quickly sales are expanding or contracting versus the comparison period.
Gross profit0Interpret alongside the company’s history, sector peers, reporting period and data source.
Operating income-22.71MInterpret alongside the company’s history, sector peers, reporting period and data source.
Net income-18.33MInterpret alongside the company’s history, sector peers, reporting period and data source.
EPS (reported period)-0.38Earnings per share for the stored reporting period; confirm whether the figure is quarterly, annual or trailing twelve months before comparing it with valuation multiples.
EPS growth-97.96%Interpret alongside the company’s history, sector peers, reporting period and data source.
Gross margin+0.00%Share of revenue left after direct costs; higher margins can indicate pricing power.
Operating margin-703.63%Share of revenue left after operating expenses, before interest and taxes.
Net margin-567.86%Share of revenue that remains as profit after expenses and taxes.
EBITDA-22.05MInterpret alongside the company’s history, sector peers, reporting period and data source.
EBIT-22.71MInterpret alongside the company’s history, sector peers, reporting period and data source.
Cash & equivalents371.63MInterpret alongside the company’s history, sector peers, reporting period and data source.
Total assets576.8MInterpret alongside the company’s history, sector peers, reporting period and data source.
Total liabilities70.69MInterpret alongside the company’s history, sector peers, reporting period and data source.
Total debt0Interpret alongside the company’s history, sector peers, reporting period and data source.
Shareholders equity506.11MInterpret alongside the company’s history, sector peers, reporting period and data source.
Current assets543.94MInterpret alongside the company’s history, sector peers, reporting period and data source.
Current liabilities27.91MInterpret alongside the company’s history, sector peers, reporting period and data source.
Operating cash flow-24.53MInterpret alongside the company’s history, sector peers, reporting period and data source.
Capital expenditure1.85MInterpret alongside the company’s history, sector peers, reporting period and data source.
Free cash flow-26.38MCash remaining after operating needs and capital expenditure; can support investment or shareholder returns.
FCF margin-817.45%Interpret alongside the company’s history, sector peers, reporting period and data source.
Return on equity-3.62%Profit generated relative to book equity; leverage and one-off gains can distort it.
Return on assets-3.18%Interpret alongside the company’s history, sector peers, reporting period and data source.
Debt / equity0Debt relative to shareholder equity; definitions may vary by data provider.
Price / sales267.34Interpret alongside the company’s history, sector peers, reporting period and data source.
Price / book1.7Interpret alongside the company’s history, sector peers, reporting period and data source.
EV / revenue152.17Interpret alongside the company’s history, sector peers, reporting period and data source.
Earnings yield-2.14%Interpret alongside the company’s history, sector peers, reporting period and data source.
Shares outstanding48,630,038Interpret alongside the company’s history, sector peers, reporting period and data source.
Book value / share10.41Interpret alongside the company’s history, sector peers, reporting period and data source.
FCF / share-0.54Interpret alongside the company’s history, sector peers, reporting period and data source.
Market cap862.7MMarket value of outstanding shares, not the same as enterprise value.
52-week high34.19Highest stored price over the rolling year; not a fair-value estimate.
52-week low14.72Lowest stored price over the rolling year; not a support guarantee.
Average volume353,400Typical shares traded; helps assess liquidity but can change around events.
TECHNICALS

Technical indicators

Latest stored daily indicator snapshot; unavailable indicators are omitted.

Oct 20, 2026
RSI (14)19.11Momentum oscillator from 0–100; extreme readings are context, not automatic buy/sell signals.
SMA 2018.17Average closing price over about 20 trading sessions; a short-term trend reference.
SMA 5022.04Average closing price over about 50 sessions; often used to assess medium-term direction.
SMA 10023.13Interpret alongside the company’s history, sector peers, reporting period and data source.
EMA 2018.16Interpret alongside the company’s history, sector peers, reporting period and data source.
EMA 5020.66Interpret alongside the company’s history, sector peers, reporting period and data source.
MACD-1.86Interpret alongside the company’s history, sector peers, reporting period and data source.
MACD signal-1.7Interpret alongside the company’s history, sector peers, reporting period and data source.
MACD histogram-0.17Difference between MACD and its signal line; sign and changes indicate momentum shifts.
Bollinger upper21.55Interpret alongside the company’s history, sector peers, reporting period and data source.
Bollinger middle18.17Interpret alongside the company’s history, sector peers, reporting period and data source.
Bollinger lower14.79Interpret alongside the company’s history, sector peers, reporting period and data source.
Stochastic5.62Interpret alongside the company’s history, sector peers, reporting period and data source.
Stochastic signal5.1973580294611Interpret alongside the company’s history, sector peers, reporting period and data source.
Williams %R-94.38Interpret alongside the company’s history, sector peers, reporting period and data source.
CCI-163.68Interpret alongside the company’s history, sector peers, reporting period and data source.
MFI13.64Interpret alongside the company’s history, sector peers, reporting period and data source.
ROC-18.30%Interpret alongside the company’s history, sector peers, reporting period and data source.
OBV-7.38MInterpret alongside the company’s history, sector peers, reporting period and data source.
Momentum-18.3Interpret alongside the company’s history, sector peers, reporting period and data source.
Volatility+50.47%Interpret alongside the company’s history, sector peers, reporting period and data source.
ATR0.96Average true range estimates recent price movement size, not direction.
ADX68.91Measures trend strength, not whether the trend is bullish or bearish.
Support level14.84Interpret alongside the company’s history, sector peers, reporting period and data source.
Resistance level22.22Interpret alongside the company’s history, sector peers, reporting period and data source.
REPORTED RESULTS

Financial statements, earnings history and estimate revisions

Recent normalized financial statement records.

Showing up to 60 recent statement records. Reported periods and statement types are preserved; blank values are not estimated. Contradictory zero sentinels are withheld instead of presented as verified facts.

PeriodStatementFiscal periodBasisRevenueCost of revenueGross profitOperating incomeNet incomeBasic EPSDiluted EPSCashTotal assetsTotal liabilitiesDebtEquityOperating cash flowCapexFree cash flowSource
Mar 31, 2026balance sheetFY-2026-Q1quarterly———————371.63M576.8M70.69M0506.11M———3spread
Mar 31, 2026cash flowFY-2026-Q1quarterly————————————-24.53M1.85M-26.38M3spread
Mar 31, 2026income statementFY-2026-Q1quarterly3.23M00-22.71M-18.33M-0.38-0.38————————3spread
Dec 31, 2025balance sheetFY-2025-Q4quarterly———————37.78M264.89M77.63M0-146.15M———3spread
Mar 31, 2025cash flowFY-2025-Q1quarterly————————————-17.54M1.89M-19.43M3spread
Mar 31, 2025income statementFY-2025-Q1quarterly1.45M—0-18.14M-14.99M-18.60-18.60————————3spread

Financial metric history

PeriodRevenue growthGross marginOperating marginNet marginROEROIC
Mar 31, 2026+123.01%+0.00%-703.63%-567.86%-3.62%—

Earnings history

These are SEC-reported financial facts grouped by fiscal period. The displayed date is the SEC filing/observation date, not a verified earnings announcement or release date. Use the company’s investor-relations calendar for confirmed earnings-release timing.

SEC filing / observation dateFiscal periodEPS reportedEPS estimateRevenue reportedRevenue estimate
Aug 13, 2026Q2-0.44—3.38M—
May 11, 2026Q1-0.38—3.23M—
VALUATION

Stock valuation: P/E, forward P/E and multiples

Multiples shown only when the database has a usable value.

Price / sales267.34
Price / book1.7
Enterprise value491.07M

Peer comparisons are withheld until a comparable industry group and a reliable peer set are verified.

LATEST DEVELOPMENTS

News and company updates

Stories linked to this stock in the current database.

RISK CONTEXT

Risk and performance profile

Computed risk/performance records; not a recommendation. Mathematically uninterpretable or extreme ratios are withheld rather than displayed as reliable facts.

Volatility+46.73%
Beta1.51
ATR1.02
Maximum drawdown-44.96%
Sharpe ratio-0.12
Sortino ratio-0.12
Debt / equity0
Current ratio19.49
1-day return-1.44%
5-day return-3.56%
1-month return-33.97%
3-month return-43.77%
6-month return+2.82%
All-time return-20.27%
RESEARCH EVIDENCE

Source data and research records

Expandable evidence tables keep the main page focused while preserving detailed data.

Institutional holders and ownership

Showing up to 50 recent holder records. Values failing a basic implied-price check are withheld, not silently corrected.

PeriodFiledHolderCIKSharesValueOwnershipShares changeChange %Source
Jun 30, 2026Aug 14, 2026Octagon Capital Advisors LP1839435960,84730.97M———SEC_13F_DATASET
Jun 30, 2026Aug 5, 2026Caitong International Asset Management Co., Ltd19633558258———SEC_13F_DATASET
Jun 30, 2026Aug 4, 2026POLEN CAPITAL MANAGEMENT LLC103452463,5142.05M———SEC_13F_DATASET
Jun 30, 2026Aug 13, 2026MORGAN STANLEY8954217,341236.6K———SEC_13F_DATASET
Jun 30, 2026Aug 11, 2026Allworth Financial LP15551701244K———SEC_13F_DATASET
Jun 30, 2026Aug 11, 2026MERCER GLOBAL ADVISORS INC /ADV8537582,97895.98K———SEC_13F_DATASET
Jun 30, 2026Jul 23, 2026Police & Firemen's Retirement System of New Jersey20406865,530178.23K———SEC_13F_DATASET
Jun 30, 2026Aug 14, 2026Freestone Grove Partners LP2007591264———SEC_13F_DATASET
Jun 30, 2026Aug 14, 2026SUSQUEHANNA INTERNATIONAL GROUP, LLP14461948,623277.92K———SEC_13F_DATASET
Jun 30, 2026Aug 14, 2026Legal & General Group Plc7640682,06266.62K———SEC_13F_DATASET
Jun 30, 2026Aug 14, 2026WELLINGTON MANAGEMENT GROUP LLP9022191,953,34462.96M———SEC_13F_DATASET
Jun 30, 2026Aug 12, 2026Integrated Wealth Concepts LLC17371093109.99K———SEC_13F_DATASET
Jun 30, 2026Aug 11, 2026Tower Research Capital LLC (TRC)15334212,26873.1K———SEC_13F_DATASET
Jun 30, 2026Aug 14, 2026T. Rowe Price Investment Management, Inc.18976122,051,447Withheld: value fails validation———SEC_13F_DATASET
Jun 30, 2026Aug 14, 2026MPM BIOIMPACT LLC16870784,835,872155.86M———SEC_13F_DATASET
Jun 30, 2026Aug 14, 2026Ghisallo Capital Management LLC182521425,000805.75K———SEC_13F_DATASET
Jun 30, 2026Aug 14, 2026ROYAL BANK OF CANADA100027563520K———SEC_13F_DATASET
Jun 30, 2026Aug 6, 2026ROTHSCHILD INVESTMENT LLC85338391.26K———SEC_13F_DATASET
Jun 30, 2026Aug 10, 2026Essential Partners LLC21364424129———SEC_13F_DATASET
Jun 30, 2026Aug 12, 2026GEODE CAPITAL MANAGEMENT, LLC1214717447,64514.43M———SEC_13F_DATASET
Jun 30, 2026Aug 13, 2026Vanguard Global Advisers, LLC18112426,886221.94K———SEC_13F_DATASET
Jun 30, 2026Aug 11, 2026Blue Owl Capital Holdings LP18587033,070,21998.95M———SEC_13F_DATASET
Jun 30, 2026Aug 7, 2026SG Americas Securities, LLC13133603,368Withheld: value fails validation———SEC_13F_DATASET
Jun 30, 2026Aug 13, 2026VANGUARD PORTFOLIO MANAGEMENT LLC2100121145,2204.68M———SEC_13F_DATASET
Jun 30, 2026Aug 7, 2026DEUTSCHE BANK AG\94804620,714667.61K———SEC_13F_DATASET
Jun 30, 2026Jul 21, 2026LANARK FINANCIAL, INC.7915405,358172.69K———SEC_13F_DATASET
Jun 30, 2026Aug 7, 2026Covestor Ltd190984623Withheld: value fails validation———SEC_13F_DATASET
Jun 30, 2026Aug 14, 2026Invesco Ltd.9142088,717280.95K———SEC_13F_DATASET
Jun 30, 2026Aug 14, 2026WELLS FARGO & COMPANY/MN7297118,856607.73K———SEC_13F_DATASET
Jun 30, 2026Aug 7, 2026PNC Financial Services Group, Inc.7136765,900190.16K———SEC_13F_DATASET
Jun 30, 2026Jul 14, 2026SALEM INVESTMENT COUNSELORS INC8844231,00032.23K———SEC_13F_DATASET
Jun 30, 2026Aug 6, 2026Global Retirement Partners, LLC174974439512.73K———SEC_13F_DATASET
Jun 30, 2026Aug 14, 2026Jupiter Topco LLC21460521,314,26742.36M———SEC_13F_DATASET
Jun 30, 2026Aug 13, 2026LOS ANGELES CAPITAL MANAGEMENT LLC117720614,379463.44K———SEC_13F_DATASET
Jun 30, 2026Aug 14, 2026RTW INVESTMENTS, LP14932151,592,04351.31M———SEC_13F_DATASET
Jun 30, 2026Aug 14, 2026Quarry LP1965207341.1K———SEC_13F_DATASET
Jun 30, 2026Aug 6, 2026AXQ CAPITAL, LP19169087,020226.26K———SEC_13F_DATASET
Jun 30, 2026Aug 6, 2026Clearstead Advisors, LLC8427756195———SEC_13F_DATASET
Jun 30, 2026Aug 4, 2026Rossby Financial, LCC205651018580———SEC_13F_DATASET
Jun 30, 2026Jul 17, 2026Farther Finance Advisors, LLC1992825772.41K———SEC_13F_DATASET
Jun 30, 2026Aug 6, 2026WPG Advisers, LLC206734325806———SEC_13F_DATASET
Jun 30, 2026Aug 14, 2026BAKER BROS. ADVISORS LP1263508996,35132.11M———SEC_13F_DATASET
Jun 30, 2026Aug 14, 2026SOROS FUND MANAGEMENT LLC1029160100,0003.22M———SEC_13F_DATASET
Jun 30, 2026Aug 3, 2026CITIGROUP INC83100111,953385.25K———SEC_13F_DATASET
Jun 30, 2026Aug 14, 2026Alyeska Investment Group, L.P.1453072290,0009.35M———SEC_13F_DATASET
Jun 30, 2026Aug 13, 2026VANGUARD CAPITAL MANAGEMENT LLC2100119817,07526.33M———SEC_13F_DATASET
Jun 30, 2026Aug 13, 2026Rockefeller Capital Management L.P.173943939712.8K———SEC_13F_DATASET
Jun 30, 2026Aug 10, 2026GREAT LAKES ADVISORS, LLC107801343,6121.41M———SEC_13F_DATASET
Jun 30, 2026Aug 13, 2026Tidal Investments LLC160006457,0591.84M———SEC_13F_DATASET
Jun 30, 2026Aug 14, 2026CHARLES SCHWAB INVESTMENT MANAGEMENT INC884546166,8425.38M———SEC_13F_DATASET
PeriodShares outstandingInstitutional ownershipInsider ownership
Jun 30, 202648,630,038+68.21%+0.03%
Insider transactions

Reported transaction values and remaining holdings are shown only when supplied by the source.

Transaction dateFiledInsiderTitleTypeCodeSharesPriceReported valueShares afterFilingSource
Sep 23, 2026Sep 24, 2026Czibere AkosChief Medical OfficerOption ExerciseM12,5004.9561.88K12,500Open filingSEC_FORM_3_4_5
Sep 23, 2026Sep 24, 2026Czibere AkosChief Medical OfficerSaleS5,09920.19102.97K7,401Open filingSEC_FORM_3_4_5
Sep 23, 2026Sep 24, 2026Czibere AkosChief Medical OfficerSaleS7,40121.03155.65K0Open filingSEC_FORM_3_4_5
SEC filings

Showing up to 30 latest filings. Open the original SEC document when a URL is available.

FiledAcceptedFormDescriptionReporting periodAccessionSEC document
Sep 24, 2026—44Sep 23, 20260001193125-26-401014View filing
Sep 23, 2026—144——0001950047-26-009770View filing
Aug 13, 2026—10-Q10-QJun 30, 20260001193125-26-349144View filing
Aug 13, 2026—8-K8-KAug 13, 20260001193125-26-349133View filing
Jul 21, 2026—44Jul 20, 20260001193125-26-310991View filing
Jul 20, 2026—44Jul 17, 20260001193125-26-309115View filing
Jul 20, 2026—144——0001950047-26-007234View filing
Jul 17, 2026—144——0001950047-26-007199View filing
Jul 10, 2026—44Jul 8, 20260001193125-26-300163View filing
Jul 10, 2026—44Jul 8, 20260001193125-26-300162View filing
Jul 8, 2026—144——0001950047-26-006961View filing
Jul 8, 2026—144——0001950047-26-006960View filing
May 11, 2026—10-Q10-QMar 31, 20260001193125-26-216749View filing
May 11, 2026—8-K8-KMay 11, 20260001193125-26-216716View filing
Apr 16, 2026—33Apr 15, 20260001193125-26-158968View filing
Apr 16, 2026—8-K8-KApr 15, 20260001193125-26-158944View filing
Apr 16, 2026—44Apr 15, 20260001193125-26-159028View filing
Mar 30, 2026—8-K8-KMar 30, 20260001193125-26-132524View filing
Mar 30, 2026—10-K10-KDec 31, 20250001193125-26-131748View filing
Jan 15, 2026—33Jan 12, 20260001193125-26-013467View filing
Jan 14, 2026—4—Jan 12, 20260001473930-26-000005View filing
Jan 14, 2026—4—Jan 12, 20260001231919-26-000057View filing
Jan 14, 2026—4—Jan 12, 20260001231919-26-000055View filing
Jan 12, 2026—44Jan 12, 20260001193125-26-010575View filing
Jan 12, 2026—8-K8-KJan 12, 20260001193125-26-010354View filing
Jan 12, 2026—44Jan 12, 20260001193125-26-010617View filing
Jan 12, 2026—44Jan 12, 20260001193125-26-010566View filing
Jan 12, 2026—4—Jan 12, 20260000935836-26-000031View filing
Jan 8, 2026—3—Jan 8, 20260001231919-26-000024View filing
Jan 8, 2026—33Jan 8, 20260001193125-26-008058View filing
Quarterly and monthly research
PeriodResearch summary
Mar 31, 2026Derived quarterly snapshot; AI narrative pending
Mar 31, 2026Latest reported fundamentals for fiscal period FY-2026-Q1. Revenue: $3227000. Revenue growth: 123.01%. EPS: $-0.380. EPS growth: -97.96%. Gross margin: 0.00%. Operating margin: -703.63%. Net margin: -567.86%. Free cash flow: $-26379000.
MonthResearch summary
Oct 1, 2026Derived monthly snapshot; AI narrative pending
Third-party metrics and ratios

Showing up to 40 recent metric records and 40 ratio records from the query window. Provider periods, units and validity flags are preserved when available.

PeriodReport periodFiscal yearQuarterPeriod typeCategoryValueUnitCurrencyValidSource
Jun 30, 2026Jun 30, 202620262semiannualother_operating_activities-1,562,000—USDYes3Spread
Jun 30, 2026Jun 30, 202620262semiannualgeneral_and_administrative-12,900,000—USDYes3Spread
Jun 30, 2026Jun 30, 202620262semiannualstock_issuance_costs-2,263,000—USDYes3Spread
Jun 30, 2026Jun 30, 202620262semiannualresearch_and_development-45,316,000—USDYes3Spread
Jun 30, 2026Jun 30, 202620262instantcommon_stock5,000—USDYes3Spread
Jun 30, 2026Jun 30, 202620262instantaccounts_payable2,533,000USDUSDYes3Spread
Jun 30, 2026Jun 30, 202620262semiannualaccrued_capital_expenditures472,000USDUSDYes3Spread
Jun 30, 2026Jun 30, 202620262instantaccrued_expenses10,778,000USDUSDYes3Spread
Jun 30, 2026Jun 30, 202620262instantaccumulated_other_comprehensive_income-745,000USDUSDYes3Spread
Jun 30, 2026Jun 30, 202620262instantadditional_paid_in_capital684,611,000USDUSDYes3Spread
Jun 30, 2026Jun 30, 202620262semiannualcapital_expenditures-3,116,000USDUSDYes3Spread
Jun 30, 2026Jun 30, 202620262instantcash_and_equivalents82,491,000USDUSDYes3Spread
Jun 30, 2026Jun 30, 202620262semiannualcash_beginning_of_period38,933,000USDUSDYes3Spread
Jun 30, 2026Jun 30, 202620262semiannualcash_end_of_period83,640,000USDUSDYes3Spread
Jun 30, 2026Jun 30, 202620262semiannualchange_in_accounts_payable801,000USDUSDYes3Spread
Jun 30, 2026Jun 30, 202620262semiannualchange_in_accrued_liabilities2,808,000USDUSDYes3Spread
Jun 30, 2026Jun 30, 202620262semiannualchange_in_deferred_revenue-6,611,000USDUSDYes3Spread
Jun 30, 2026Jun 30, 202620262semiannualchange_in_other_assets-1,988,000USDUSDYes3Spread
Jun 30, 2026Jun 30, 202620262semiannualchange_in_other_liabilities-677,000USDUSDYes3Spread
Jun 30, 2026Jun 30, 202620262semiannualchange_in_prepaid_expenses-2,447,000USDUSDYes3Spread
Jun 30, 2026Jun 30, 202620262semiannualchange_in_receivables-1,249,000USDUSDYes3Spread
Jun 30, 2026Jun 30, 202620262quarterlycomprehensive_income504,000USDUSDYes3Spread
Jun 30, 2026Jun 30, 202620262instantcurrent_assets524,539,000USDUSDYes3Spread
Jun 30, 2026Jun 30, 202620262instantcurrent_liabilities32,128,000USDUSDYes3Spread
Jun 30, 2026Jun 30, 202620262instantdeferred_revenue_current17,339,000USDUSDYes3Spread
Jun 30, 2026Jun 30, 202620262instantdeferred_revenue_noncurrent30,868,000USDUSDYes3Spread
Jun 30, 2026Jun 30, 202620262semiannualdepreciation_and_amortization1,531,000USDUSDYes3Spread
Jun 30, 2026Jun 30, 202620262quarterlyeps_basic-0.44USD/shareUSDYes3Spread
Jun 30, 2026Jun 30, 202620262semiannualeps_diluted-0.82USD/shareUSDYes3Spread
Jun 30, 2026Jun 30, 202620262semiannualinterest_and_investment_income9,149,000USDUSDYes3Spread
Jun 30, 2026Jun 30, 202620262instantlease_liability_current1,478,000USDUSDYes3Spread
Jun 30, 2026Jun 30, 202620262instantlease_liability_noncurrent9,762,000USDUSDYes3Spread
Jun 30, 2026Jun 30, 202620262semiannualnet_cash_financing337,703,000USDUSDYes3Spread
Jun 30, 2026Jun 30, 202620262semiannualnet_cash_investing-248,167,000USDUSDYes3Spread
Jun 30, 2026Jun 30, 202620262semiannualnet_cash_operating-45,616,000USDUSDYes3Spread
Jun 30, 2026Jun 30, 202620262semiannualnet_change_in_cash44,707,000USDUSDYes3Spread
Jun 30, 2026Jun 30, 202620262semiannualnet_income-42,469,000USDUSDYes3Spread
Jun 30, 2026Jun 30, 202620262semiannualnet_income_starting_line-42,469,000USDUSDYes3Spread
Jun 30, 2026Jun 30, 202620262instantnet_property_plant_equipment15,966,000USDUSDYes3Spread
Jun 30, 2026Jun 30, 202620262semiannualnon_cash_investing_and_financing337,865,000USDUSDYes3Spread
PeriodReport periodFiscal yearQuarterPeriod typeRatio categoryRatioValuePercentileMissing inputsValidSource
Jun 30, 2026Jun 30, 202620262quarterlyprofitabilitygross_margin_pct0+0.00%gross_profitNo3Spread
Jun 30, 2026Jun 30, 202620262quarterlyleverageinterest_coverage0+0.00%interest_expenseNo3Spread
Jun 30, 2026Jun 30, 202620262quarterlyefficiencyinventory_turnover0+0.00%cost_of_revenue,inventoryNo3Spread
Jun 30, 2026Jun 30, 202620262quarterlyefficiencyreceivables_turnover0+0.00%receivablesNo3Spread
Jun 30, 2026Jun 30, 202620262quarterlyefficiencyasset_turnover0.01+0.00%—Yes3Spread
Jun 30, 2026Jun 30, 202620262quarterlyliquiditycash_ratio2.57+0.00%—Yes3Spread
Jun 30, 2026Jun 30, 202620262quarterlycash_flowcf_margin_pct-623.26+0.00%—Yes3Spread
Jun 30, 2026Jun 30, 202620262quarterlycash_flowcf_to_net_income0.87+0.00%—Yes3Spread
Jun 30, 2026Jun 30, 202620262quarterlyliquiditycurrent_ratio16.33+0.00%—Yes3Spread
Jun 30, 2026Jun 30, 202620262quarterlyleveragedebt_to_assets0.13+0.00%—Yes3Spread
Jun 30, 2026Jun 30, 202620262quarterlysectordebt_to_ebitda-2.6+0.00%—Yes3Spread
Jun 30, 2026Jun 30, 202620262quarterlyleveragedebt_to_equity0.15+0.00%—Yes3Spread
Jun 30, 2026Jun 30, 202620262quarterlysectorebitda_margin_pct-828.01+0.00%—Yes3Spread
Jun 30, 2026Jun 30, 202620262quarterlyleverageequity_multiplier1.15+0.00%—Yes3Spread
Jun 30, 2026Jun 30, 202620262quarterlycash_flowfree_cash_flow-22,353,000+0.00%—Yes3Spread
Jun 30, 2026Jun 30, 202620262quarterlyprofitabilitynet_margin_pct-713.48+0.00%—Yes3Spread
Jun 30, 2026Jun 30, 202620262quarterlycash_flowoperating_cf_ratio-0.66+0.00%—Yes3Spread
Jun 30, 2026Jun 30, 202620262quarterlyprofitabilityoperating_margin_pct-853.99+0.00%—Yes3Spread
Jun 30, 2026Jun 30, 202620262quarterlyliquidityquick_ratio16.33+0.00%—Yes3Spread
Jun 30, 2026Jun 30, 202620262quarterlyprofitabilityroa_pct-4.33+0.00%—Yes3Spread
Jun 30, 2026Jun 30, 202620262quarterlyprofitabilityroe_pct-4.98+0.00%—Yes3Spread
Jun 30, 2026Jun 30, 202620262quarterlyliquidityworking_capital492,411,000+0.00%—Yes3Spread
Mar 31, 2026Mar 31, 202620261quarterlyprofitabilitygross_margin_pct0+0.00%gross_profitNo3Spread
Mar 31, 2026Mar 31, 202620261quarterlyleverageinterest_coverage0+0.00%interest_expenseNo3Spread
Mar 31, 2026Mar 31, 202620261quarterlyefficiencyinventory_turnover0+0.00%cost_of_revenue,inventoryNo3Spread
Mar 31, 2026Mar 31, 202620261quarterlyefficiencyreceivables_turnover0+0.00%receivablesNo3Spread
Mar 31, 2026Mar 31, 202620261quarterlyefficiencyasset_turnover0.01+5.25%—Yes3Spread
Mar 31, 2026Mar 31, 202620261quarterlyliquiditycash_ratio13.31+97.94%—Yes3Spread
Mar 31, 2026Mar 31, 202620261quarterlycash_flowcf_margin_pct-759.99+3.08%—Yes3Spread
Mar 31, 2026Mar 31, 202620261quarterlycash_flowcf_to_net_income1.34+63.55%—Yes3Spread
Mar 31, 2026Mar 31, 202620261quarterlyliquiditycurrent_ratio19.49+97.28%—Yes3Spread
Mar 31, 2026Mar 31, 202620261quarterlyleveragedebt_to_assets0.12+9.16%—Yes3Spread
Mar 31, 2026Mar 31, 202620261quarterlysectordebt_to_ebitda-3.21+19.69%—Yes3Spread
Mar 31, 2026Mar 31, 202620261quarterlyleveragedebt_to_equity0.14+19.06%—Yes3Spread
Mar 31, 2026Mar 31, 202620261quarterlysectorebitda_margin_pct-683.42+3.71%—Yes3Spread
Mar 31, 2026Mar 31, 202620261quarterlyleverageequity_multiplier1.14+18.42%—Yes3Spread
Mar 31, 2026Mar 31, 202620261quarterlycash_flowfree_cash_flow-26,379,000+21.14%—Yes3Spread
Mar 31, 2026Mar 31, 202620261quarterlyprofitabilitynet_margin_pct-567.86+3.86%—Yes3Spread
Mar 31, 2026Mar 31, 202620261quarterlycash_flowoperating_cf_ratio-0.88+8.67%—Yes3Spread
Mar 31, 2026Mar 31, 202620261quarterlyprofitabilityoperating_margin_pct-703.63+3.71%—Yes3Spread
Data quality and provenance

This page does not fill gaps with sample data. Values shown above come from the connected market-data and research tables.

No verified records available for this section yet.
RetrievedDatasetProviderStatus
Oct 8, 2026company_profileUS Market AI / SEC-mapped universeVerified
Identifiers and model evaluation
IdentifierValueSource
cik2035832stocks.cik
tickerAKTSstocks.symbol
No verified records available for this section yet.
QUICK ANSWERS

Frequently asked questions

What is AKTS stock's current price?

The latest stored quote for AKTS is 15.11. The quote timestamp is 10/19/2026, 4:00:00 AM. Prices can change during market hours.

What is the AKTS stock forecast and analysis?

The latest available quantitative model signal is “neutral”. Review the forecast horizons alongside the company's reported financials, valuation, technical indicators and risks below; model outputs are estimates, not guarantees or personalized investment advice.

What is the AKTS stock price target?

The forecast table shows stored quantitative model outputs for the available horizons. These are model targets, not necessarily Wall Street analyst consensus; a verified consensus target is not assumed unless explicitly stored.

What is the AKTS stock price prediction for 2030?

A stored long-term model scenario for 2030 is shown in the forecast table. Long-range scenarios are highly uncertain and should be reviewed alongside the model version and assumptions.

What are the bullish and bearish views on AKTS?

A sufficiently detailed analyst-opinion dataset is not currently stored for this stock. The bull and bear cases on this page are conditional evidence-based scenarios, not attributed analyst recommendations.

What is the AKTS stock price prediction for 2026?

A verified 2026 long-term model output is not currently stored for this stock. Check the forecast section for available horizons rather than relying on an unsupported target.

Is AKTS stock overvalued or undervalued?

The database does not currently contain a usable trailing P/E value. Without verified valuation inputs and a suitable comparison set, this page cannot responsibly label the shares overvalued or undervalued.

What is AKTS's P/E ratio?

A usable trailing P/E ratio is not currently available in the stored valuation data.

What is AKTS's 52-week high and low?

The stored 52-week range is 14.72 to 34.19. This describes the recent trading range, not a forecast or a guaranteed support/resistance level.

Does AKTS pay a dividend, and what is its dividend history?

No dividend records are currently stored for this stock. That absence does not prove the company pays no dividend.

When is AKTS's next earnings report?

The latest SEC filing/observation date in this database is Aug 13, 2026. This is not a verified earnings announcement date or a confirmed next-report date; check company investor relations for the official calendar.

How has AKTS stock performed recently?

The price chart uses 195 stored daily observations, and the market snapshot includes the latest available quote. Use the chart to inspect the period shown; past performance does not predict future returns.

Is AKTS stock in a bullish or bearish trend?

The required technical indicator data is incomplete, so a reliable bullish/bearish trend label is not available.

What are the main risks of investing in AKTS?

Available risk metrics are shown in the risk and performance section. These metrics do not capture every business, competitive, regulatory or market risk; review company filings and disclosures as well.

Where can I find AKTS's financial statements and earnings history?

Use the Financial Statements section for stored statement records, financial metric history, earnings results and estimate revisions. Coverage depends on the data available for this company.

Does US Market AI provide a guaranteed AKTS price target?

No. Forecasts shown here are quantitative model outputs, not guarantees or personalized financial advice. Missing forecast values are left unavailable rather than filled with invented targets.

KEEP EXPLORING

Related Healthcare stocks

Other active stocks in this sector. This is a directory, not a performance ranking.

Browse all stocks ↗
LLYEli Lilly & Co.Healthcare1.05T market capJNJJohnson & JohnsonHealthcare630.04B market capABBVABBVIE INC.Healthcare483B market capMRKMerck & Co., Inc.Healthcare359.22B market cap
US MARKET AI · STOCK RESEARCH

Data availability varies by company and provider. Missing values are omitted rather than estimated. Forecasts are model outputs and should be independently evaluated.

Research updated Oct 19, 2026 · Research methodology · Disclaimer